TY  - JOUR

T1  - Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

JO  - The Lancet Oncology

PY  - 2014/06/01

AU  - Sartor O

AU  - Coleman R

AU  - Nilsson S

AU  - Heinrich D

AU  - Helle SI

AU  - O'Sullivan JM

AU  - Fosså SD

AU  - Chodacki A

AU  - Wiechno P

AU  - Logue J

AU  - Widmark A et al

ED  - 

DO  - DOI: 10.1016/s1470-2045(14)70183-4

PB  - Elsevier BV

VL  - 15

IS  - 7

SP  - 738

EP  - 746

Y2  - 2025/10/10

ER  -